Navigation Links
DaVita Becomes the First FORTUNE 500 Healthcare Services Company to Join the EPA Green Power Partnership
Date:5/12/2009

Program Offsets Carbon Footprint at DaVita's Six Corporate Business Offices

EL SEGUNDO, Calif., May 12 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced that the company is the first FORTUNE 500 healthcare services company to join the Environmental Protection Agency (EPA) Green Power Partnership program. Joining this program is part of DaVita's mission to educate patients, caregivers and the rest of the healthcare community on the importance of utilizing environmentally-friendly power alternatives to ensure a healthy future for all.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

Through the program, DaVita will offset 10,000,000 kilowatts of energy - enough to power DaVita's six largest corporate business offices for an entire year - through the utilization of renewable wind energy. The offset is the equivalent of removing 1,315 passenger vehicles from the road, or reducing the strain placed on local power grids by the amount of power consumed by approximately 1,000 American homes.

"Providing life-saving treatment for our patients requires adapting to the needs of an ever-changing world," said Misha Palecek, Divisional Vice President and DaVita Village Green(TM) Program Director. "Our patients expect high quality service and support, and we encourage our patients, caregivers, partners and the rest of the industry to join us in this important effort."

This commitment to green business and carbon footprint management is part of DaVita Village Green, a program designed to reduce the environmental impact of the company's business practices. DaVita Village Green is dedica
'/>"/>

SOURCE DaVita Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. DaVita Announces Completion of Government Investigation
2. DaVita Donates More Than $1 Million in Scholarship Funds for Teammates Families
3. DaVita 1st Quarter 2009 Results
4. DaVita Wins Silver in Web Health Awards
5. DaVita Honored as First and Only FORTUNE 500 Company to Make List of Democratic Workplaces Since Its Inception in 1999
6. DaVita Dietitian Receives 2009 National Kidney Foundation Award for Outstanding Contributions to Renal Health
7. DaVita Wins Recruiting Department of the Year Award
8. Natalie Cole Lauds DaVita and CEO Kent Thiry on Larry King Live
9. DaVitas Customized Lifestyle Management Programs Assist Employees to Meet Their Lifestyle Goals
10. DaVitas IMPACT Program Reduces Mortality for New Dialysis Patients
11. DaVita Raises Awareness on World Kidney Day

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...LOSANGELES,Nov.25/PRNewswire-USNewswire/--TheBlack...odetermineexecutiveleadershipfor2010. ,, Thenew...cialtiesinpublicpolicy,law,finance,governmenthealt...eBoardalsocomesfromawiderangeofpersonalbackgrounds...melivingwithHIVthemselves,andrepresentingmultiplea...
(Date:11/25/2009)...erm survivors of testicular cancer who were treate...e side effects, including neurological side effect...t treated with chemotherapy, according to a new st...f the National Cancer Institute . , Marianne Bry... University Hospital, in Bergen, Norway, and colle...
(Date:11/25/2009)...tress increase blood pressure? This simple questi... years. New Stress-related gene Modulates High Bl...blood pressure? This simple question has been the...w research has for the first time established a li...pressure response to stress in mice as well as hum...
(Date:11/25/2009)... Evaluation and treatment clinics... Woodstock (Vocus) November 25, 2009 -- Centegr...vaccines and H1N1 vaccine shots at four Centegra P...r shipment of vaccine has arrived. The clinics are...and McHenry and will be open as follows: , &nb...
(Date:11/25/2009)...positive note, CDC sees few signs of trouble with ...5 (HealthDay News) -- The ongoing H1N1 swine flu p... pneumonias among younger patients, a U.S. health ...crease in serious pneumococcal infections around t...tional Center for Immunization and Respiratory Dis...
Breaking Medicine News(10 mins):Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4
...mericans diagnosed with primary open angle glaucom...or the condition according to a study. Th...rapy use in the U.S. to utilize longitudinal data ...ed 65 and older by analyzing data collected from 1...
...nistration (FDA) today issued a formal written req...l devices remaining in the marketplace, including...ns. On April 17, 2007, U.S. Marshals, at F...'s manufacturing processes. During the seizure, Sh...
...ght not only face the risk of developing health di...they are also likely to face the risk of developi...r 17 years, the study - by researchers at the Canc...for men and 85 for women significantly increases c...
...nistration (FDA) is warning pharmaceutical manufac...essionals who compound medications to be especial... commonly used worldwide in liquid over-the-counte...the agency is issuing guidance to industry recomme...
... as the most brisk walkers in the world, as the sp...en percent in the last decade. In a sampl... on top followed by citizens of Copenhagen, Madrid...the study. But walking fast is not good f...
...Bobby Robson is ready to fight against cancer for ...ho said that he was diagnosed with cancer for the ...y last week after cancerous nodules were discovere...e greatest news I've ever had but I have fought ha...
Other Medicine News:Health News:FDA Advises Manufacturers to Test Glycerin for Possible Contamination 2Health News:Bobby Robson Diagnosed With Cancer for Fifth Time 2
(Date:11/25/2009)...stCall/--NuVasive,Inc.(Nasdaq: NUVA ),amedicaldevi...sruptivesurgicaltreatmentsforthespine,announcedtod...,2009,at5:30p.m.ET/2:30p.m.PT.Theconferencecallwil...Company,sproductsandwillincludecommentsfrommanagem...l-innumbersare1-877-407-4018fordomesticcallersand1...
(Date:11/25/2009)...portlinker.comannouncesthatanewmarketresearchrepor...elivery-USMarketTrends&Analysis http://www.re...-US-Market-Trends--Analysis.html ,, TheUSintra...erapeuticapplicationsfromthedeliveryofconventional...euticdrugs.Thefutureofthetechnologyhingesontotheef...
(Date:11/25/2009)...ewswire/-- ChemoCentryx,Inc.,announcedtodaythatPh...ProspectiveRandomizedOralTherapyEvaluationinCrohn,...swithmoderate-to-severeCrohn,sdiseasedemonstratedc...profile.Thestudydemonstratedevidenceofclinicaleffi...pointdecreaseintheCrohn,sDiseaseActivityIndex(CDAI...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Study finds colorectal cancer rates increasing worldwide 8769 1Study finds colorectal cancer rates increasing worldwide 8769 2Pharmacy Organizations Brief Congress on Medication Therapy Management 48343 1Pharmacy Organizations Brief Congress on Medication Therapy Management 48343 2Pharmacy Organizations Brief Congress on Medication Therapy Management 48343 3Lumbar Spinal Stenosis Surgery at the Olympia Medical Center 48340 1Lumbar Spinal Stenosis Surgery at the Olympia Medical Center 48340 2
... for Presentation at 47th ICAAC on ..., Sept. 4 Ardea Biosciences,Inc. (Pink Sheets: AR...eted,Phase 1 single-ascending-dose, multiple-ascen...es of RDEA806, a novel HIV non-nucleoside reverse,...eers. The data from these Phase 1 clinical trials...
...ive analysis of,clinical trials known as a meta-an...tent was associated with significantly lower risks...mpared to the Taxus Stent out to 30,months after a...randomized,clinical trials and 8,695 patients, the...ed on the Journal of the American College of Cardi...
Other Medicine Technology:Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806 2Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806 3Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent 2Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent 3Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent 4
Anterior Stromal Puncture Cannula, 25 g
Viscoelastic Cannula, 23 g. Angled
Anterior Chamber Needle, 21 g
Anterior Chamber Needle, 25 g. Angled
Medicine Products: